PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ... [Yahoo! Finance]
PDS Biotechnology Corporation (PDSB)
Last pds biotechnology corporation earnings: 11/7 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Research and Development Expenses: Increased to approximately $6.8 million for Q3 2024, up from $6.4 million in Q3 2023. General and Administrative Expenses: Decreased to approximately $3.4 million for Q3 2024, from $4.1 million in Q3 2023. Operating Expenses: Decreased to approximately $10.2 million for Q3 2024, down from $10.5 million in Q3 2023. Net Interest Expenses: Increased to approximately $0.5 million for Q3 2024, up from $0.3 million in Q3 2023. Cash and Cash Equivalents: Totaled approximately $50 million as of September 30, 2024. Warning! GuruFocus has detected 1 Warning Sign with PDSB. Release Date: November 14, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Strong interest from investors and investigators in the VERSATILE-003 Phase III trial, indicating confidence in the study's potential. Updated VERSATILE-003 trial design aims to reduce costs and time to achieve interim data readout while maint
Show less
Read more
Impact Snapshot
Event Time:
PDSB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PDSB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PDSB alerts
High impacting PDS Biotechnology Corporation news events
Weekly update
A roundup of the hottest topics
PDSB
News
- PDS Biotech Leadership to Participate in March ConferencesGlobeNewswire
- PDS Biotechnology Co. (NASDAQ: PDSB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.MarketBeat
- PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck CancerGlobeNewswire
- PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewswire
- PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA OncologyGlobeNewswire
PDSB
Earnings
- 11/14/24 - In-Line
PDSB
Sec Filings
- 3/7/25 - Form 8-K
- 3/3/25 - Form 4
- 3/3/25 - Form 4
- PDSB's page on the SEC website